NanoString Chairman Sees Dx Opportunity for 'Elegantly Simple' Technology

William Young said the firm's platform — which uses digital barcoding to enable multiplexed, direct profiling of individual molecules in a single reaction without amplification — is currently deployed for research purposes, but he sees a big opportunity in diagnostics and pharmacogenomics.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories